Dutch Society of Nephrology  by unknown
Hyperfiltration and proteinuria in male Fawn Hooded (FH)-rats with
two intact kidneys developing spontaneous hypertension. M.H. Dc Kejzer,
A.P. Provoost. Department of Pediatric Surgery, Erasmus University,
Rotterdam, The Netherlands. Male FHrats are prone to the early
development of a syndrome consisting of focal glomerulosclerosis,
proteinuria and hypertension. These animals die prematurely of malig-
nant nephrosclerosis. Comparison of the renal function of male FH-rats
with either weight—matched or age—matched male Wistar (WAG) rats
revealed that the FH-rats had a higher mean glomerular filtration rate
(GFR) and a higher filtration fraction (FF). Within the total group of
male FH-rats (N = 14), two cohorts could be distinguished on the basis
of their urinary protein excretion. Class I FH-rats (N =6) excreting
'normal' amounts of protein and Class II rats (N = 8) showing overt
proteinuria (>25 mg/l00 g body wt per 24 hr). A difference in protein-
uria was already present at the age of 10 weeks. Rats of both classes
developed hypertension. However, the systolic blood pressure (SBP) of
Class II rats was significantly higher than that of Class I rats from week
35. Until week 50 the GFR of class II rats was slightly higher and the
ERPF slightly lower than that of Class I rats. As a consequence the FF
of Class II rats was significantly higher than that of Class I rats up to
week 50. In Class I rats the GFR remained stable during the 80 week
follow—up period. In contrast Class II rats showed a decrease in GFR
and ERPF from week 50, and subsequently rats died because of renal
failure. The normal life span of male WAG rats with two intact kidneys
is about three years, while they usually die of causes other than renal
failure. We think that in male FH-rats, especially in those of Class II,
the combination of a high FF and proteinuria points to glomerular
hypertension. Such a glomerular hypertension causes glomerular scle-
rosis and development of terminal renal failure in rats with initially two
intact kidneys. The degree of proteinuria at young age may be of
significance to classify the rats prone to develop renal failure.
The pathophysiology of protein—overload proteinuria. J.J. Weening,
C. van Guldener, A.M.v.d, Wa!, M.R. Daha. Departments of Pathol-
ogy and Nephrology, State University of Leiden, Leiden, The Nether-
lands. Increased passage of proteins from the glomerular capillary
lumen to the urinary space has been observed in man and in laboratory
animals after parenteral administration of high amounts of proteins. The
pathogenesis of this type of protein—overload proteinuria was studied in
rats rendered proteinuric by administration of two daily injections of
1.25 g bovine serum albumin (BSA), After the second dose, urinary
protein loss increased from 16 5 mg to 320 93 mg per 24 hrs. At the
time of massive proteinuria, changes in glomerular permeability were
studied by measuring GFR and RPF, and the fractional clearances of
three differently—charged peroxidases, of heterologous IgG and 1gM
and of rat serum albumin (RSA) and BSA. In addition, morphological
studies were performed to assess glomerular structural changes by light
and electron microscopy after 1 and 2 doses of BSA and four days after
the second dose of nSA, when proteinuria had disappeared. The
functional studies revealed in proteinuric rats (1) unchanged glomerular
filtration rate and renal plasma flow; (2) a 34-fold increase in C/GFR of
rat serum albumin reaching values similar to BSA; (3) a twofold
increase in C/GFR for anionic horse radish peroxidase (HRP), but
normal values for neutral and cationic HRP, and (4) a 3- and 10-fold
increase for heterologous IgG and 1gM, respectively. In proteinuric
rats, glomerular epithelial cells showed degenerative changes with loss
of foot processes, numerous protein reabsorption droplets and focal
detachment of the glomerular basement membrane. These changes
were almost completely absent in rats that had received only one dose
of BSA and in rats, four days after the second dose of BSA. The
distribution of anionic sites in the glomerular basement membrane was
found to be unaltered as determined by polyethyleneimine binding
studies. In summary, an elevation of serum albumin concentration
results in an increased transcapillary albumin transport. This leads to
degenerative changes of the glomerular epithelial cells with develop-
ment of large pore defects. In the rat strain studied, all changes were
found to be reversible. Studies by others have shown progression of
glomerular lesions and proteinuria after protein overload, a discrepancy
with the present findings which may be due to genetically determined
differences in the glomerular response (hemodynamic?metabolic?) to
protein overload and epithelial cell damage.
Prednisolone increases glomerular permeability in patients with a
nephrotic syndrome. J.F.M. Wetzels, H. E. Sluiter, A. J. Hoitsma, P. J.
J. v Munster, R.A.P. Koene. Department of Medicine, Division of
Nephrology and Laboratory of Pediatrics, St. Radboud Hospital,
University of NUmegen, Nzjmegen, The Netherlands. In patients with a
nephrotic syndrome administration of prednisone in an alternate day
regimen causes a fluctuating pattern of proteinuria, due to an increased
protein excretion rate on prednisone days and a decreased protein
excretion rate on non-prednisone days. To study the mechanism of this
phenomenon we have measured the acute proteinuric effect of predni-
solone (P) in nine patients (7 M, 2 F) with a nephrotic syndrome. Mean
age (± SEM) of the patients was 53 2 years, mean endogenous
creatinine clearance (ECC) 104 10 mI/mm and mean proteinuria 7.7
1.0 g/24 hr. Glomerular filtration rate (GFR, inulin clearance), renal
plasma flow (ERPF, PAH clearance) and urinary excretion of total
protein, albumin, IgG, transferrin and 13-2-microglobulin (/3-2-M; N = 7)
were measured from 1.5 hours before till 5 hours after administration of
P, 125 to 150 mg (i.v.). After administration of P, urinary total protein
excretion rose in all patients from 4,89 0.59 mg/mm before to 9.09
0.99 mg/mm at five hours after administration of the drug (P < 0.01).
GFR, ERPF, or ifitration fraction did not change significantly (GFR
70.4 8.6vs. 73.1 10.1 mI/mm, ERPF 509 52 vs. 545 79 mI/mm,
FF 0.143 0.012 vs. 0.140 0.001), The increase in urinary excretion
of albumin (from 4.39 0.49 to 8.23 0.88 mg/mm) was comparable to
the increase of both transferrin and IgG excretion (respectively from
0.324 0.061 to0.650 0.111 mg/minandfromo.127 0.O3OtoO.295
0.072 mg/mm). Urinary excretion of f3-2-M did not change signifi-
cantly, however. In conclusion: intravenous administration of predni-
solone to patients with a nephrotic syndrome causes an increase in
urinary protein excretion rate which cannot be explained by changes in
renal hemodynamics or tubular protein reabsorption, and which there-
fore must be the result of a change in glomerular permselectivity
characteristics.
Presymptomatic diagnosis of adult pulycystic kidney disease using DNA
markers. M.H. Breuning, S.T. Reeders, B.L. Hogewind, A.L. van Es,
P.L. Pearson. Department of Human Genetics, State University Leiden,
Leiden, The Netherlands. Recently the gene for adult polycystic kidney
disease (APKD) has been localized to the short arm of chromosome 16.
We have studied the inheritance of APKD in 20 large Dutch families. In
all families analyzed thusfar, the mutation responsible for the disease
was found to be closely linked to a hypervariable region 8 kilobases
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downstream from the alpha globin genes (3'HVR) on chromosome 16.
However, in 5% of the family members the gene for APKD and 3'HVR
were separated by recombination during meiosis. The linkage between
the gene for APKD and markers on chromosome 16 can be used for
presymptomatic, and prenatal diagnosis. A family study is always
necessary in order to identify the chromosome carrying the mutation.
The recombination rate of 5% represents the number of false predic-
tions when only the 3'HVR marker is used. In the near future the
identification of flanking markers on chromosome 16 will greatly
improve the reliability of these predictions. In young adults at risk for
APKD ultrasonography is the most widely used method for presymp-
tomatic diagnosis. In different studies the number of false negative
results of ultrasonography at 20 to 30 years of age has ranged between
5 and 14%. At that age family members of patients can be especially
keen on knowing whether they have inherited the gene for the disease.
In young adults at risk for APKD with no cysts demonstrable by
ultrasonography, a family study including DNA markers for chromo-
some 16 can greatly improve the reliability of the prediction whether the
patient has indeed inherited the unaffected gene.
Human plasma contains sodium transport stimulating factors. 7'.
Tepper, R.M. Huisman, J.F. Jilderda, G.K. van der Hem, D. de
Zeeuw. State University Hospital, Groningen, The Netherlands. Mea-
surement of cell sodium transport using efflux rate constants (ERC) has
been considered of value in the diagnosis of essential hypertension.
However, many conflicting data have been reported from studies using
either plasma or artificial media. The aim of this study was to establish
whether differences in ERC occur if plasma and artificial media are
compared in the same assay. Using erythrocytes of six normal volun-
teers, total, ouabain—sensitive, and furosemide—sensitive ERC were
determined in plasma and two current artificial media of plasma—like
composition. Briefly, the ERC is derived from the decrease in radioac-
tivity of 22Na-loaded erythrocytes after suspension in plasma or artifi-
cial medium at 37°C. We observed: A mean total ERC of 0.49 0.10;
0.43 0.08 and 0.36 0.07 (hr') in plasma, Hanks' solution, and
Basic Salt Solution, respectively. The significantly (P < 0.05) lower
ERC in both artificial media can be attributed to a decrease in the
ouabain—sensitive and a (smaller) increase in the furosemide—sensitive
ERC. When the measurements were repeated in five individuals on six
occasions over a period of several weeks, a fairly constant ERC in
plasma was found (CV: 2.6%). In artificial medium significantly more
variation was noticed (CV: 6.0%). The addition of purified human
albumin to artificial medium did not cause a change in ERC and can
therefore not explain the lower ERC value in artificial medium. Adding
artificial medium to plasma resulted in an ERC decrease only with more
than 40% (vol/vol) dilution. Dialysis of plasma against artificial medium
over a membrane with molecular weight cut—off of 1000 daltons resulted
in a gradual ERC decrease to the value obtained in the medium. In
conclusion this study indicates the presence of a dialysable plasma
sodium transport stimulating factor(s), which is present in excess,
varies in quantity from day—to—day and has an apparent molecular
weight below 1000 daltons. These findings are of methodological
importance when ERC measurements are used in the diagnosis and the
search for underlying causes of hypertension.
Decreased diluting segment reabsorption in Bartter's syndrome. R.J.
Hené, H.A. Koomans, E.J. Dorhout Mees. Department of Nephrology,
University Hospital, Utrecht, The Netherlands. Bartter's syndrome has
been attributed to a NaC1 reabsorption defect somewhere in the diluting
segment, because maximal free—water clearances (CH2O) is too low
relative to the distal delivery (DD = CH2O + CChloride). This ratio
(CH2O/DD) was only 0.60 or less in five such patients presented by Gill
and Bartter. However, in a number of recent reports of patients with the
clinical picture of Bartter's syndrome this ratio was not below 0.60, and
it was suggested that in earlier cases CH2O/DD was spuriously low due
to high KC1 supplies or hypotonic NaCI infusions during clearance
tests. Normally, the value of CH2O/DD decreases with increasing DD,
and depends upon NaCl intake. Thus CH2O/DD in Bartter's syndrome
should be compared to data from normals with similar rates of DD. We
plotted the fractional CH2O against the fractional DD of five patients
studied in our department and of 24 cases assembled from the literature,
and compared the data with those obtained in 44 studies in normals on
a wide range of NaCI intake (20, 200 or about 1000 mmol). The analysis
showed that in 26 patients CH2O was lower than in normals at a similar
rate of DD, indicating that diluting segment reabsorption was impaired
in most cases. However, this impairment was mostly moderate, and
very low values for CH2O (<0.60) were found in only 10 cases. This
subset concerned patients with reduced glomerular filtration rate or
patients subjected to salt loading. DD was low relative to sodium intake(compensatory rise in proximal" reabsorption) with the same excep-
tion of patients who had a low glomerular filtration rate or were studied
during salt loading. We conclude that, in contrast to recently raised
opinions, diluting segment reabsorption is decreased in most patients
with Bartter's syndrome.
Does atrial natriuretic peptide (ANP) cause the altered renal sodium
handling of essential hypertension (EH)? W.M.T. Janssen, P.E. de Jong,
G.K. van der Hem, D. de Zeeuw. Division of Nephrology, State
University Hospital, Groningen, The Netherlands. Patients with EH
have an altered renal sodium handling. During conditions of water
loading (WL) and hydropenia (HP) for instance, sodium excretion is
enhanced in EH with a concomitant, lower free—water generation
(CH2O) during WL, and a lower free—water reabsorption (TH2o) during
HP. Moreover, plasma levels of ANP have been found to be higher in
patients with EH, which has been suggested to be a compensatory
response to a defective renal sodium handling in EH. To test whether
the altered renal sodium handling in EH is ANP-related, we studied the
effects of 1.0 g a-h-ANP/min for 80 to 120 minutes in 7 NT and 6 EH
subjects on 3 test days: basal conditions (B), WL, and HP with
mannitol. The table shows the effects of ANP (last 40 to 60 mm of
infusion) as mean SEM per cent change from control values of that test
day (°P  0.05).
Hypertensives
Basal WL HP
MAP —2±2 +1±1 +2±1
FENa +111 47° +106 21° +44 6°
GFR +7±2° +3±4 +5±2°
ERPF —11±2° —3±3
FF +l5±4a +l6±2a +11±4°
CH2O/GFR
TCH2O/GFR
Uosm
—
—
—40 6
+20 2°
—
+10 7
—9 3a
—6 ia
MAP
Normotensives
Basal
—3±1
WL
+1±1
HP
+2±2
FEN +67 27° +159 58 +89 25°
GFR +4 l +7 3 +6 2
ERPF —6±3 —6±3
FF +18±5° +15±4° +l2±4a
CH2O/GFR
TcH2O/GFR
Uosm
—
—
—18 23
+ 11 4°
—
+8 6
—
—10 4°
—8 3
Our results indicate that ANP exerts a distinct natriuretic effect in EH
and NT. Although no statistically significant differences were observed
between the marked effects of ANP in both groups, CH2O/GFR tended
to increase more in EH (P = 0.1). Ifendogenous ANP is responsible for
the phenomenon of exaggerated natriuresis in EH, CH2O/GFR should
have increased less and FENa should have increased more in EH after
exogenous ANP. Finding the opposite, we conclude that ANP is not
responsible for the phenomenon of exaggerated natriuresis in EH, and
that the renal responses to exogenous ANP are not statistically different
between EH and NT.
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Effects of mdomethacln (Indo) on sodium balance and on renal response
to atrial natriuretic peptlde (ANP). C.A. Gaillard, H.A. Koomans, AL
Rabelink, E.J. Dorhout Mees. Dept. Nephrology, State University of
Utrecht, The Netherlands. We studied the effects of 7 days of Indo (50
mg t.i.d.) on sodium balance and response to ANP in 8 healthy subjects
balanced on 100 mmol Na daily. Indo caused a markedly positive Na
balance (244 57 mmol) in 6 days, when sodium output had returned to
baseline. Renal Na handling (maximal free—water clearance) was stud-
ied in three 20 minute clearance periods before and after an i.v. bolus of
100 g ahANP, with and without Indo. Baseline studies with and
without Indo indicated that Indo caused increased fractional "proxi-
mal" reabsorption of Na (FPRNa) in correspondence with a fall in
fractional lithium excretion (FELi). Fractional "distal" reabsorption of
Na (FDRNa) was suppressed. ANP caused an equal natriuresis (UNaV)
with and without Indo, via a rise in glomerular filtration rate (C-in) and
a fall in FPRNa and in FDRNa. The fall in FPRNa and rise in FELi after
ANP were larger during Indo (P 0.05), and the influence of Indo to
raise FPRNa was nullified by ANP. This also held for distal delivery,
which decreased by Indo and increased by ANP. We conclude that Indo
causes considerable Na retention in humans on an intermediate Na
intake. After escape from the Na retention the natnuresis after ANP is
not blunted. This ANP-natriuresis appears not mediated by or depen-
dent on renal prostaglandins.
without Indo with Indo
baseline ANP baseline ANP
C-in ml/min
FPRNa %
FDRNa %
FELi %
UNaV i.unol/min
115 ga
89.4 0.8a
91.5 l.8
28.7 2.2a
119 23
128 9
86.7 1.3
83.0 2.8
34.5 2.4
404 117
107 5
92.5 0.7
87.7 l.7
20.5 l.6a
119 2l
113 4
87.3 1.5
74.7 3.7
29.5 2.4
503 108
a P < 0.05: mean SEM)
Antibodies to purified renal tubular epithelial antigens contain activity
against glomerular basement membrane (GBM) components laminin,
fibronectin and type IV collagen. P.C. W. Hogendoorn, J.A. Bruzjn, E.
de Heer, J.M. Foidart, L.J.C.M. v.d. Broek, P.H.J. Hoedemaeker,
G.J. Fleuren. Department of Pathology, University of Leiden, The
Netherlands and Department of Obstetrics and Gynecology, University
ofLiege, Belgium. Antibodies (Ab) directed against tubular brushbor-
der antigens (Fx1A) are used to induce heterologous immunecomplex
glomerulonephritis. Among these antigens a glycoprotein of 330 kd
molecular weight (OP 330) has been shown to be of pathogenic
significance. We investigated whether Ab other than those directed
against GP 330 are present in anti-FxlA and whether they play a
pathogenetic role. Polyclonal rabbit Ab directed against crude FxIA
and against RTEgp, a purified glycoprotein present in FxIA, were
analyzed for the presence of activity directed against laminin, fibro-
nectin and type IV collagen, by ELISA and by Western blotting. Both
Ab preparations predominantly bound to the 220 kd subunit of laminin
and at a lower, but distinct level to fibronectin and type IV collagen.
Two rat monoclonal Ab directed against GP 330 failed to do so,
excluding cross—reactivity between anti-OP 330 and the tested GBM
components. Indirect immunofluorescence (IF) with the Ab fraction
directed against GBM that had been isolated by affinity chromatography
from anti-FxlA IgG, showed linear binding to the GBM on normal
kidneys. Intravenous injection of these affinity purified Ab in Wistar
rats showed a linear IF pattern and induced a weak and transient
protcinuria. Immuno-EM demonstrated binding to cell membranes of
glomerular endothelial and epithelial cells and to lamina rara interna of
the GBM. Injection of anti-FxlA devoid of anti-GBM activity by
absorption resulted in deposition of Ab in a fine granular pattern along
the GBM. In contrast, injection of unabsorbed anti-FxlA resulted in a
coarse granular pattern. The presence of Ab (cross) reacting with
laminin, fibronectin and type IV collagen in anti-Fx1A Ab might well be
of pathogenetic significance and could explain earlier described differ-
ences in pathogenicity between monospecific anti-OP 330 Ab and
polyclonal anti-Fx1A Ab.
The bone marrow in patients with IGA nephropathy: A possible origin
of mesangial IGA. A. W.L. van den Wall Bake, M.R. Daha, J. Radl, J.J.
Haajjman, A. van der Ark, L.A. van Es. University of Leiden, IvEG-
TNO and MBL-TNO RUswUk, The Netherlands. To determine the site
of production of the polymeric IgAl present in the circulation and
mesangium of patients with IgA nephropathy, we compared the bone
marrow of 14 patients with 19 control subjects. Cytospin preparations
were assessed for cells containing cytoplasmic IgA, IgAl, and IgA2
using double immunofluorescence with isotype and subclass specific
monoclonals. Scoring was performed blindly by two observers, and
proved to be reliable (r = 0.94). In addition the bone marrows were
cultured for 7 days, and the immunoglobulins produced were assessed
with ELISA. Means SD were compared with Student's 1-test.
Immunofluorescence showed an increase in the percentage of IgA
containing plasmacells (45.8 7.2 vs. 40.1 10.5% in controls, P =
0.08), and a significant increase in the IgAl fraction of total IgA
plasmacells (89.9 2.7 vs. 84.1 6.7%, P < 0.01). The IgA2 fraction
was correspondingly low in patients (7.4 3.0 vs. 13.5 5.9%, P <
0.01). Spontaneous production of IgA in culture was higher in patients
(1648 1151 vs. 1078 937 ng in controls, P = 0.12). The ratio of
spontaneous IgAl production to total IgA production was significantly
increased in patients (95.8 2.2 vs. 89.9 6.4%, P < 0.01). No
significant differences were found in IgG and 1gM production. These
findings suggest that the bone marrow is a site of long—term overpro-
duction of IgAl in IgA nephropathy.
Hantavirus disease (HVD) in Belgium: Clinical and epidemiological
data. J. Clement, A. Lefevre, G. van der Groen. Military Hospital
Brussels, Institute of Tropical Medicine Antwerp, Belgium. HVD is a
newly recognized, rodent—borne zoonose with the kidney as main target
organ. It is caused by different strains of Hantaviruses (HV), forming a
new genus in the Bunyaviridae family and having probably a worldwide
distribution. The clinical picture consists of aspecific viral symptoms,
initial thrombocytopenia and a variable degree of ARF, mostly with
marked proteinuria due to interstitial nephritis. Since 1983 several
sporadic cases of a mild form of HVD have been reported throughout
Europe (1 case in the Netherlands), mostly with a benign, self—limiting
course. Diagnosis can only be ascertained by detecting in the patients'
serum specific anti-HV antibodies by the indirect immunofluorescent
assay (IFA) or variant techniques, whereby at least 4 different sero-
types can be distinguished. Four recent Belgian cases of HVD are
briefly described: the highest value of serum creatinine noted was 6.3
mg% and the highest proteinuria was 3.3 g/liter, whereas the lowest
platelet count was 45,000/mm3. Two patients presented transient myo-
pia and diplopia, I patient had a bout of epistaxis. Highest serum
dilution noted with still characteristic IFA was 1/8192 for CG18-20 and
1/8192 for PH-antigen (case 3). All patients lived near or in forested
areas. In a prospective sero-epidemiological study of a standard civilian
population in Belgium, a total N of 12,767 sera were screened for
Hantaan (76-118 strain) antibodies: 205 (1.6%) were found positive (titer
1/16, with a significantly higher ( = 23.3, P < 0.001) prevalence in
the densely forested, south—eastern part of Belgium (2.2% positivity)
than in the north—western part (1%). In a parallel military study, 65 sera
(0.9 1%) were found positive on a total N of 7123. Forces with frequent
open field activities versus forces with few or no field activities showed
a higher degree of seropositivity. HVD should be added to the etiolog-
ical list of ARF.
Intensive follow—up improves the prognosis of adult polycystic disease
(APK). R. Verberckmoes, P. Michielsen. University Hospital, K. U.L.
Leuven, Belgium. The rate of decrease of renal function in APK during
a control period (before 1980: period I) was compared with the
progression during a period of intensive follow—up (since 1980: period 2)
during which treatment was standardized with special attention to
patient information, dietary advice (reduced protein intake and weight
control), and control of hypertension. Progression of renal disease was
estimated by the linear regression coefficient of clearance of creatinine
(Car, according to Cockroft and Gault corrected for body surface area)
vs. time. Criteria for admission in the study were: initial Cc,. <40
mI/mm, a follow—up period of more than 2 years with at least 6
ambulatory controls while the patients (pts) were in a steady state
condition. Renal function deteriorated more slowly in period 2 (22 pts)
than in period 1 (15 pts) (P = 0.0001). Mean age was lower and initial
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C higher in period 1. In order to examine whether these differences
could explain the result, individual pts of period I were matched for
both variables with pts of period 2. Eight pairs of pts could be matched
so that the individual differences were maximally five years or 5 mI/mm
whereas mean age and initial Crwere identical. Progression of renal
failure was again significantly slower in the 8 pts from period 2 (P =
0.025). A weak but significant correlation was found between the rate of
deterioration and diastolic, but not systolic blood pressure, explaining
only partly the better prognosis in period 2. Extrapolation of the
regression curves of renal function shows that the rate of progression of
renal disease during period 2 is compatible with the hypothesis that the
renal lesion in APK starts in early childhood.
99mTcMAG is not suitable for the determination of the effective renal
plasma flow (ERPF). G.H. Schaap, R.B.J. de Jong, T.H.R. Alferink,
J.C. Roos, A.J.M. Donker. Departments of Internal Medicine and
Nuclear Medicine, Free University Hospital, Amsterdam, The Nether-
lands. Studies on renal circulation often are using radiolabelled hip-
puran. Disadvantages of its use are a relatively high radiation dose, high
costs and a poor availability. Animal studies have shown that mTc
labeled to MAG3 also might be suitable for this purpose because of its
high renal clearance. In this study '311-hippurate (1311-OIH) and s9mTc
MAG3 (labeling always > 96%) were administered simultaneously in 16
patients (GFR ranging from 17 to 120 ml/min/l .73 m2) to measure ERPF
using the standard technique (U.V/P). GFR ('251-thalamate = '2510T)
was measured as well. The mean ratio of mTcMAG3 to '311-OIH
amounted to 0.54 0.02 (sEM), P < 0.01, and did neither depend on
GFR nor ERPF. To study the cause of the difference in renal handling
of both radiopharmaceuticals, renal extractions by the right kidney
were determined in another 6 patients after a single shot of those agents.
Renal extraction of mTcMAG3 was 0.60 0.03 after 5, and 0.41
0.08 after 30 minutes. Renal extraction of '311-OIH amounted to 0.86
0.04 and 0.75 0.06, respectively. Using renal extractions of 0.41 and
0.75, respectively, it appeared that calculated RPF measured simulta-
neously with ssmTcMAG3 and '311-OIH was similar. Albumin binding
in vivo 30 minutes after the priming dose amounted to 66% for
DSmTcMAG3 and 47% for 1231-OIH. We conclude that in spite of a high
renal clearance (ratio to '2510T 2.69 0.27), 9smTcMAG3 is not
suitable for the determination of the ERPF, the more not because the
ratio of s9mTcMAG3 to '311-OIH decreased markedly in patients with
substantial urinary protein loss. For renal scanning, however, 99mTc..
MAG3 might be a good alternative for '311-OIH in man, as was
previously shown in animal studies.
The handling of three renal radiopharmaceuticals in rats with one
non-filtering kidney. A.P. Provoost, M. van Aken. Department of
Pediatric Surgery, Erasmus University, Rotterdam, The Netherlands.
The renal handling of two static renal imaging agents, mTcDimercap.
tosuccinic acid (Tc-DMSA) and mTcaprotinin (Tc-Apr), was com-
pared with that of mTcdiethylenetnaminepentaacetic acid (Tc-DTPA), a
true marker of glomerular filtration only. For this purpose rats were
used with one intact and one non-filtering kidney, that is 24 hours after
a complete unilateral ureteral obstruction. The renal and bladder
accumulation of mTc was determined with a gammacamera attached
to a dedicated computer system (GAMMA 11). The radioactivity
present 60 minutes after the i.v. injection of the markers was expressed
as a percentage of the amount injected (% I).
Intact
kidney%I
Bladder
%I
Obstructed
kidney%I
Total
%I
Obstructed
kidney
%Total
DTPA 1.3 0.2 80.0 3.7 3.9 1.1 85.1 3.0 4.6 1.4
DMSA 28.3 4.4 9.9 1.7 6.9 2.1 45.2 6.5 15.2 2.8a
Apr 37.3 4.7 1.4 0.3 5.0 2.0 43.7 5.1 11.5 4.la
ap< 0.05 vs. DTPA
The amount of Tc-DMSA and Tc-Apr present in the obstructed kidney,
as a % of the total amount handled by both kidneys (last column), was
significantly higher than the amount of Tc-DTPA. This indicates that
next to glomerular filtration and subsequent tubular reabsorption other
processes, like peritubular uptake, play a role in the renal handling of
the two static imaging agents. For Tc-DMSA, being structurally related
to succinic acid, this may be a pathway handling di- and tricarboxylic
acids, like for instance citrate. For TcApr, being a peptide, peritubular
uptake is likely as it has been described for insulin. In conclusion, both
Tc-DMSA and Tc-Apr are very suitable agents for renal imaging. Due
to the complex nature in which they are handled by the kidney,
depending on filtration, tubular reabsorption, peritubular uptake and
intracellular binding, great care has to be taken when they are used for
the quantification of renal function.
No antihypertensive effects of /3-blockers in renal graft recipients
without host kidneys. F.T.M. Huysmans, F.H.J.A. van Heusden, A.J.
Hoitsma, J.F.M. Wetzels, R.A.P. Koene. Department of Nephrology,
University Hospital, Nmegen, The Netherlands. In an analysis of 440
renal graft recipients we found that host kidneys (HK) contribute
considerably to the prevalence of persistent hypertension (HT). This
role of HK is especially clear in patients with glomerulonephritis (GN)
and less prominent in patients with interstitial nephritis (IN) as the
original renal disease (ORD). It has been suggested that HK cause HT
after renal transplantation (TP) by an increased renin production.
Therefore, we retrospectively studied the antihypertensive effect of a
/3-blocker in the first year after TP in patients with HK in situ and in
those who underwent bilateral nephrectomy (BN). Only patients with a
stable renal function, who used no other antihypertensive drug but
chlorthalidone, were evaluated. Patients with transplant renal artery
stenosis, acute rejection, proven recurrence of ORD or chronic vascu-
lar rejection, or with a proteinuria over 1.0 g/liter were excluded. At
least 3 blood pressure (BP) measurements within 2 months before as
well as after the start of a fixed dose of a /3-blocker were required for
evaluation. If HK were in situ, BP (mm Hg) decreased during /3-
blockade in 10 IN patients by —6.8 1.6% from 172 5/104 3 to 161
5/97 3 (P < 0.005) and even more (P < 0.005) in 16 GN patients by
—13.9 1.3% from 162 3/104 1 to 140 3/89 2(P <0.001). In
contrast, BP did not change (—1.7 1.0%) in 10 BN patients, being 165
6/108 3 before and 165 7/105 3 mm Hg during /3-blockade.
Doses of /3-blocker, pretreatment-BP, endogenous creatinine clearance,
or age did not differ between IN, GN, and BN patients. Chlorthalidone
did not influence the antihypertensive effect of the 13-blocker. The data
suggest that /3-blockade only reduces BP effectively, if HK are the
origin of HT. This phenomenon is possibly related to differences in
plasma renin activity or in innervation of the HK and graft, and needs
further investigation.
Combination of enalapril with hydrochiorothiazide adversely affects
metabolic control and renal function in hypertensive NIDDM-patients.
H.J.G. Bib, R.F. Westerman, A.J.M. Donker. Free University Hospi-
tal, Amsterdam, The Netherlands. Administration of the ACE-inhibitor
enalapril (E) to 15 hypertensive NIDDM-patients for six weeks resulted
in a significant blood pressure (BP) decrease, an unaltered metabolic
control and a stable renal function. In eight patients treatment goal
(diastolic BP = DBP < 90 mm Hg) was not reached, and 25 mg
hydrochlorothiazide (HCT) was added to the treatment per another six
weeks. DBP did not decrease significantly after this addition (all
comparisons: E vs. E + HCT; supine DBP, 101 4vs. 95 10mm Hg,P = 0.22; standing DBP, 99 9vs. 95 15mm Hg, P = 0.53, mean
SD), but fasting blood glucose rose significantly (8.7 3.5 vs. 9.9 3.4
mmol/liter, P < 0.05). Glucose and insulin levels were significantly
higher at various time points during a standardized liquid meal test of 3
hours duration. Areas under curve (AUC) rose as well: AUC 0 to 120
mm, 4490 948 vs. 6090 1368 mU/liter (P < 0.025); AUC 0 to 180
mm, 7410 1429 vs. 9080 1690 mU/liter (P < 0.01), mean SEM.
Creatinine levels rose: 86 14 vs. 97 15 smoI/liter (P < 0.01); and
creatinine clearance rate fell: 83 20 vs. 68 17 mllmin (P < 0.005),
mean SD. We therefore conclude that the addition of hydrochloro-
thiazide to an ACE-inhibitor in diabetic patients should be monitored
carefully, since the effects on blood pressure could be negligible, but the
effects on metabolic control and renal function considerable.
The acute effects of a single dose of prednisolone on renal circulation,
plasma renin activity and proteinuria. M. Russel, M.G. Koopman,
G.C.M. Koomen, R. T. Krediet, L. Arisz. Department of Nephrology,
Academic Medical Centre, Amsterdam, The Netherlands. In 20 patients
with proteinuria (0.5 to 15.0 g/day; mean 4.0 g/day) due to various types
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of glomerulopathies we studied the acute effects of a single dose of 25
mg prednisolone (P), administered intravenously at noon. GFR (I25I
iothalamate) and ERPF ('311-hippurate) were measured by continuous
infusion and standard method during a period of 2 hours before and
after P. In 7 patients measurements were continued till 6 hours after P.
Urinary albumin excretion and clearance were determined during 2
hours before P and 0 to 2, 2 to 4 and 4 to 6 hours after P. PRA was
analyzed before (0) and 1/2, 1, 2 and 4 hours after Pin 7 patients. During
the study the patients were seated in a chair. In the first two hours after
P GFR did not change (99% of initial value), ERPF decreased to 88% (P
'C 0.01) and FT increased to 115% (P C 0.001). These changes were
even larger 2 to 4 hours after P. No changes in GFR, ERPF en FF were
observed in 20 control patients (no P) during the same time of the day.
Changes in PRA were inconsistent. Urinary albumin excretion did not
change 0 to 2 hours after P (104%), but increased to 124% (P c 0.05) of
the value before P in the period of 2 to 6 hours after P. Similar changes
were seen in albumin clearance. No correlation was found between the
percentage of increase in FF and in albumin excretion (r = 0.060). In a
control group of 20 patients with proteinuria (no P) a significant increase
in albumin excretion during the same period of the day was absent. In
conclusion, the increase in albuminuria after P administration is pre-
ceded by an increase in FF, but the two effects are apparently
independent of each other.
Acute effects of captoprll on renal hemodynamics and albuminuria in
normotensive patients with diabetic nephropathy. L.D. Elving, J.F.M.
Wetzels, E. de Nobel, A.J. Hoitsma, J.H.M. Berden. Department of
Medicine, Divisions of General Internal Medicine and Nephrology, St.
Radboud Hospital, University of N(/megen, The Netherlands, Recent
studies have demonstrated a beneficial effect of captopril (C) on blood
pressure and albuminuria in patients with diabetic nephropathy and
hypertension. To elucidate a possible role for C in the treatment of
normotensive diabetic patients we have studied the effects of C on
hemodynamics and albumin excretion rate (APR) in nine proteinuric
diabetic patients (5 M, 4 F) with a normal blood pressure (RR < 140/90
mm Hg) with a normal renal function measured as endogenous creati-
nine clearance (FCC) 80 mI/mm/I .73 m2. Mean age (± sD) of the
patients was 35 10 years, mean duration of diabetes 24 10 years.
Blood pressure, GFR (inulin clearance), ERPF (PAH clearance), and
APR were measured from 1.5 hours before until 3 hours after a single
oral gift of C, 25 mg. Blood pressure decreased slightly, but not
significantly (130/79 4/3 vs. 124/74 4/3 mm Hg; means 5EM).
Mean APR decreased from 677 221 to 561 184 jig/mm (P C 0.01),
maximal percentual decrease ranging from —3% to —33% (median
—21%). GFR decreased from 123 13 to 117 14 mI/mm (P C 0.05;
median %:—8%), whereas ERPF increased from 609 56 to 714 55
mi/mm (P C 0.01); median %: ÷ 19%). As a result filtration fraction
(FF) decreased significantly after administration of C (0.204 0.014 vs.
0.170 0.014; P C 0.01). Albumin excretion corrected for GFR also
decreased significantly (maximal S%: median — 17%; range —4 to
—25%; P cc 0.01), indicating that the decrease of GFR hardly contrib-
uted to the decrease of albumin excretion. The decrease of APR was
significantly correlated with the decrease of FT (R = 0.75; P C 0.02).
In conclusion: Captopril, 25 mg orally, causes a prompt reduction of
APR in normotensive diabetic patients. Decrease of APR is not
mediated by a reduction of blood pressure or GFR, but by lowering of
the intraglomerular capillary pressure.
Renal hemodynamics in dogs with severe semiehronic hypoprotein-
emia. J.A. Joles, H.A. Koomans, E,J. Dorhout Mees. Department of
Nephrology, University of Utrecht, The Netherlands. Plasma colloid
osmotic pressure (COP) opposes capillary and glomerular ultrafiltra-
tion. Acute severe reduction of COP in an otherwise healthy subject
may therefore enhance glomerular filtration fraction (FF), both by
increasing filtration rate and decreasing capillary flow (reduced circu-
lating volume). In the hypoproteinemia of the nephrotic syndrome,
however, FT is usually low. But in this situation the filtration coefficient
(Kf) is low due to the glomerular disease. We studied severe semichro-
nic (14 day) hypoproteinemia induced by plasmapheresis (PT) and a
low— protein diet in II trials in 6 otherwise healthy, splenectomized
male beagle dogs.
Control Hypoproteinemia
COP mm Hg 21,5 0.8 10.4 0.8 0 C 0.00001
GFRm1/min 64±5 52±4 PO.068
RPF mI/mm 209 19 172 16 NS
FF% 31.3±0.6 31.3±2.1 NS
BV 1 1.49 0.05 1.4 0.05 NS
(n = 11, mean saM)
Mean inuiin clearance (GFR) and p-amminohippuric acid clearance
(RPF) were somewhat, but not significantly, reduced 2 days after the
last PT-session. Despite the large reduction of COP, FT was unaltered,
as blood volume (By; calculated from Evans' blue space and hemato-
crit). Thus, dogs subjected to severe semichronic hypoproteinemia can
maintain renal hemodynamics at control levels,
The syndrome of hypertension and hyperkalemla with normal GFR
(Gordon's syndrome)—study of pathophysiology. B. Semmekrot, L. Mon-
nens, B. Theelen, W. Rascher, F. Gabreels, J. Willems. Department of
Pediatrics, St. Radboud Hospital, University of Nymegen, The Neth-
erlands, A 14-year-old boy with the syndrome of hypertension and
hyperkalemia with normal glomerular filtration rate (Gordon's syn-
drome) is described. The clinical symptoms consisted of periodic
paralysis. His blood pressure was 150 to 160/105 to 110 mm Hg.
Laboratory were as follows: serum Na 136 to 138 mEq/liter, serum K"
6.5 to 7.9 mEq/liter, serum CL' 117 mEq/liter, serum HC03 14.6 mEq/
liter. Blood pH was 7.28. The metabolic acidosis was of the proximal
type. Renal function studies revealed also hypercalciuria: 8 to 15
mmoll24 hours. Both plasma renin activity and plasma aldosterone
concentration were decreased. This correlated with the increased
plasma volume measured within radioiodinated albumin. Infusion of
atrial natriuretic peptide (ANP) resulted, in contrast to controls, in no
effect on the renal function although a high blood level of ANP was
obtained and a normal rise of cyclic GMP in plasma and urine could be
demonstrated. This lack of sensitivity for ANP (a post-receptor defect?)
offers a new pathophysiological concept for Gordon's syndrome. Renal
hypoprostaglandism, mentioned in the literature, was absent. Treat-
ment with hydrochlorothiazide was effective.
Effect of water loading on lithium clearance, electrolyte excretion and
renal hemodynamics in man. W.H. Boer, H.A. Koomans, E.J. Dorhout
Mees. Department of Nephrology, University of Utrecht, The Nether-
lands. To reduce urine sampling errors during clearance studies an
adequate urine flow is often induced by oral water loads. This could
however enhance renal Na excretion, either through volume expansion
or suppression of vasopressin, which may influence tubular Na trans-
port directly or by changes in tubular flow rate. Alternatively, tubular
Na handling may change without affecting net Na excretion when
compensation takes place at other nephron levels. Indeed, studies in
dogs showed that water loads of 40 mllkg suppress proximal reabsorp-
tion without change in net Na excretion. Therefore clearance studies
were performed in 8 normal subjects on a rigorously controlled Na
intake (150 mmol/day) on 3 separate occasions during a sustained (3 hr)
low, intermediate and high (25 mI/kg body wt, maximum water diuresis)
water intake, using uric acid and lithium as a qualitative and quantita-
tive marker of proximal Na reabsorption.
Water intake Low Intermediate High
Urine flow mI/mitt 2.2 (0.9) 6.1 (0.7) 11.7 (3.0)
GFR mI/mitt 103 (15) 105 (14) 108 (13)
ERPFmI/min 566(131) 623(152) 623(166)
C-lithium mI/mm 25 (5) 25 (5) 28 (6)
FE lithium % 24 (4) 24 (4) 25 (4)
C-uric acid ml/min 9 (4) 7 (2) 8 (2)
FE-uric acid % 8 (3) 7 (2) 8 (2)
Na-excr. jimol/min 121 (65) 92 (49) 84 (42)
K-excr. jimol/min 98 (24) 93 (25) 93 (28)
log PRA fmolAI/
liter/sec 2.75 (0.31) 2.85 (0.28) 2.70 (0.35)
log PAC pmol/liter 2.55 (0.17) 2.65 (0.20) 2.62 (0.26)
Data are given as mean SD.
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Potassium excretion did not change, while Na-excretion showed a small
non-significant decrease. Renal hemodynamics or the renin—aldoster-
one axis were not affected. The lack of changes in lithium and uric acid
clearance indicate that water loads of up to 25 mI/kg body weight do not
affect proximal Na reabsorption in man. Water loads resulting in urine
flow rates between 2 and 12 mI/mm can safely be used during clearance
studies in man.
Normal relationship between sodium and lithium excretion. H.H.
Vincent, W.H. Boer, M.A.D.H. Schalekamp. Department of Internal
Medicine I, University Hospital Rotterdam and Department of Neph-
rology, University Hospital Utrecht, The Netherlands. Lithium clear-
ance (CL1) is a measure of the delivery of fluid by the proximal tubule to
the distal nephron segments. CL varies proportionally with the clear-
ance of creatinine (Car). Fractional lithium excretion (CLj/CCr) in-
creases with higher sodium intake and excretion. Thus, when using
CL1/CCr as an index of the functional integrity of the proximal tubule,
sodium excretion has to be taken into account. In this study we
examined the normal relationship between CLi/CCr and sodium excre-
tion. Fifty—five subjects with various levels of sodium intake, who did
not use diuretics, xanthine derivatives or non-steroid anti-inflammatory
drugs, were studied. Twelve hours after ingestion of lithium carbonate,
400 mg, urine was collected over two 90 minute periods to measure Cc-,
CLI/CCr, sodium excretion and fractional sodium excretion (CNa/CCr).
We found a significant linear correlation between CLj/CCr and sodium
excretion (r = 0.59). Since CNa/CCr is easier to measure than sodium
excretion, we also attempted linear regression analysis of CLi/CCr as a
function of CNa/CCr. This yielded a closer correlation (r = 0.72). The
regression equation is: CLi/CCr = 0.16 + 5.9(CNa/CCr). It shows that
physiological changes in sodium excretion may increase CLi/CCr by up
to 100%. Conclusion: When interpreting fractional lithium excretion,
allowance should be made for sodium load. This can be done by
substituting CNa/CCr in the above equation. The observed value of
CLi/CCr may then be expressed as a percentage of its predicted value
(normal 100%, SD 15%).
The relation between serum magnesium and histomorphometric bone
parameters in renal osteodystrophy. R.H. Van Rjssel, J.G.M. Jordans,
F.C. Kuipers, S.A. Duursma. Institute of Pathology, University of
Utrecht; Department of Medicine, Stadsmaten Hospital Enschede;
Laboratory of Pathology, Enschede; Department of Medicine, Univer-
sity Hospital, Utrecht, The Netherlands. The relationship has been
studied between serum magnesium concentration and histomorphometric
bone parameters in renal osteodystrophy. In 14 dialyzed patients serum
magnesium, calcium, phosphate and alkaline phosphatase were deter-
mined and, in an iliac crest biopsy specimen, morphometry was
performed. Positive correlations were found between serum magnesium
and the relative osteoid volume and osteoid surface, both parameters,
influenced by mineralization disturbances. Negative correlations were
observed between serum magnesium on one hand and the amount of
peritrabecular fibrous tissue, osteoclasts per mm2, resorbing surfaces,
osteoblastic index and serum phosphate on the other, all parameters of
hyperparathyroidism. These results support the theory that hypermag-
nesemia suppresses parathyroid function and that magnesium excess in
bone leads to impaired mineralization. The conclusion is that hyper-
magnesemia may enhance, and possibly even cause osteomalacia in
renal osteodystrophy.
Continuous arteriovenous hemofiltration (CAVH) in the critically ill.
Experience with the AN.69 plate filter. J.A. van Geelen, H.H. Vincent,
M.A.D.H. Schalekamp. Department of Internal Medicine I, University
HospitaiRotterdam, The Netherlands. Fifteen patients with acute renal
failure due to septic or cardiogenic shock were treated with CAVH for
2 to 19 days. Thirteen patients were ventilated. Ten patients had
inotropic or vasoconstrictor drugs. Their mean arterial pressure was 56
to 107 mm Hg. A 0.5 m2 polyacrylonitrile plate filter (AN-69 CSU/
CAVIl, Hospal, France) was connected via 1.25 m tubes to Shaldon
catheters in the femoral vessels. Heparin, 500 IE/hr, and substitution
fluid were infused into the arterial line (predilution). The container for
the ultrafiltrate (UF) was placed 50 cm below the filter and connected to
a suction device. If necessary, negative pressure up to —80 mm Hg was
applied to maintain UF rate 500 mI/hr. Filters were replaced in case of
blood clotting or UF rates below 300 to 400 mI/mm. Patients' average
filter life time was 48 (range 24 to 96) hour. Measurement of UF rate,
transmembrane pressure and oncotic pressures allowed calculation of
the in vivo membrane index (MI, mi/mm/mm Hg). Over the first 48
hours MI decreased with time (t, hr) according to the equation: MI = 15
— 3.1 in t (N = 37, r = 0.91, coefficient of variation = 27%). In 4
patients, at UF rates of 400 to 500 mI/mm, clearance of urea was
doubled by hemodiafiltration (CAVHD) using a concurrent dialysate
flow of 17 ml/min. There were 4 cases of active bleeding, 2 at the site of
vascular access. In 2 patients bacteremia probably originated from the
indwelling catheters. Of 15 patients 6 died while on CAVH, and 9
regained renal function. The data show that CAVH or CAVHD is feasible
in patients who are unsuited for conventional forms of dialysis. Estimation
of the membrane index may be used to plan elective filter replacement.
Effect of cuprophane reuse on intradialytic pulmonary function. R.
Vanholder, R. Pauwels, J. Van Den Bogaerde, M. Vanderstraeten, S.
Ringoir. University Hospital, Ghent, Belgium. Pulmonary function
during hemodialysis has partially been related to complement activa-
tion. Since this activation is currently seen with first use of cuprophane
and not with reuse, a better pulmonary function can be expected during
reuse. However, 2 studies evaluating this problem did not show any
difference in arterial oxygen tension (Pa02). In the present study Pa02
and more accurate parameters of pulmonary function have been com-
pared in 12 patients, on bicarbonate hemodialysis, during first use and
third reuse of cuprophane. The intradialytic evolution of leucocytosis
and serum concentration of C3a des Arg were also evaluated. As
expected, the typical leucopenia and complement activation of first use
were largely attenuated during reuse. At first use Pa02 fell from 93.0
12.4 (pre-dialysis) to a minimum of 82.8 12.6mm Hg after 60 minutes
(P < 0.01); at reuse PaO2 remained unaltered. Lung diffusion capacity
(DLCO) decreased significantly at first use (from 30.7 8.9 to 23.8
7.8 mllmin mm Hg, P < 0.01), but this change was absent after reuse.
Similarly, the pulmonary transfer factor (KCO) decreased from 6.1
1.8 to 4.7 1.6 mI/mm mm Hg during first use (P < 0.01), but not after
reuse. These data suggest a relation before and after reuse between
mntradialytic leucopenia and complement activation on one hand and
pulmonary diffusion capacity on the other.
Renal graft histology before and after late conversion from cyclosporin
to azathioprine. D.J. Versluis, F.J. W. ten Kate, G.J. Wenting, J. Jeekel,
W. Weimar. University Hospital Rotterdarn—Djkzigt, Rotterdam, The
Netherlands. After one year of continuous cyclosporine (C5A) therapy,
elective conversion to azathioprine (AZA) was successfully performed
in 14 kidney transplant recipients showing an improvement in serum
creatinine from 171 13 to 133 7 mol/liter after three months. In
these patients renal biopsies were obtained before and three months
after conversion to study the incidence and potential reversibility of
CsA related morphologic features. In the light microscopic examination
attention was separately focused on glomerular, vascular and tubular
changes, and interstitial fibrosis and cellular infiltrates. The histopatho-
logic features were "blindly" scored on a semiquantitative scale by 2
observers. Preconversion CsA levels were within the therapeutic range
(101 22 ng/ml). Glomerular changes were non-specific and mild.
Insudative artenolar lesions were seen in 5 of 14 patients all with a
serum creatinine > 150 jmol/liter (P < 0.05). These insudative lesions
disappeared in 3 of 5 cases after conversion. Arteriolar deposits of
IgM/C3 were prominent in 12 of 14 first biopsies, decreased significantly
in 9 of 12 (P < 0.05) and became negative in 7 of 12 post-conversion
biopsies. Isometric tubular vacuolization was present in 4 of 14 and
disappeared post-conversion (P < 0.05). No megamitochondria were
seen. All biopsies showed signs of mild to moderate interstitial fibrosis
which remained stable during this study. Surprisingly post-conversion
biopsies showed a significant increase of interstitial infiltrates consisting
predominantly of mononuclear cells (P < 0.05) together with an
increased percentage of tubulitis (2/14 vs. 9/14, P < 0.01). Our results
show that CsA associated arteriolopathy (insudative lesions and IgM/
C3 deposits) and isometric vacuolization significantly regress after
stopping CsA at one year after transplantation. Conversion is, however,
accompanied by an increase in mononuclear cell infiltrates and tubulitis
despite an evident improvement in renal function in all patients.
Clearance of soluble aggregates of IgG is abnormal in patients with
systemic lupus erythematosus. S. Lobatto, M.R. Daha, F.C. Breedveld,
A. Cats, E.K.J. Pauwels, A.A. Voetman, L.A. van Es. University
Hospital, Leiden and Central Laboratory of the Netherlands Red Cross
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Blood Transfusion Service, Amsterdam, The Netherlands. Mononu-
clear phagocyte system (MPS) function tested with non-complement
activating, anti-rhesus-IgG-coated red cells has shown that MPS func-
tion may be abnormal in SLE. However, soluble immune complexes
may be handled differently by the MPS. In this study, we tested MPS
function in 9 healthy controls (HC) and 15 SLE patients with comple-
ment activating '231-labelled aggregates of human IgG (AIgG). Clear-
ance half—life of AIgG was 26 8 mm in HC, compared to 58 27 mm
in patients (P < 0.005). Binding of AIgG to erythrocytes was signifi-
cantly lower in patients, 9.3 8.1 vs. 24 20% (P < 0.05). A possible
explanation for this is that increase of C3a-levels in plasma was
significantly lower in patients than in HC (P < 0.05 at 3 and 8 mm),
suggesting less complement activation. Liver and spleen uptake of
'231-AIgG was measured with a gamma camera and expressed as liver
spleen uptake (LS) ratios at 15 and 60 minutes. In patients the LS ratios
were significantly higher than in HC at 15 minutes, 3.8 2.0vs. 2.31
0.7 (P <0.05), due to less splenic uptake of AIgG. Correlations between
clearance half—life or LS ratios and immune complex levels or disease
activity were not found. In this study we have shown that clearance of
soluble AIgG is abnormal in patients with SLE due to decreased splenic
uptake of AIgG, however, without correlations with disease activity or
immune complex levels.
The effect of metoclopramide on dopamine—induced changes in renal
function in healthy controls and in patients with renal disease. A.J. Smit,
S. MeUer, H. Wesseling, A.J.M. Donker, W.D. Reitsma. Divisions of
Internal Medicine and Nephrology, Department of Medicine and
Department of Clinical Pharmacology, University Hospital Groningen,
Groningen, and Department of Medicine, Free University, Amsterdam.
The Netherlands. To characterize the effects of metoclopramide (mcp)
as a dopamine—antagonist in the human kidney and to evaluate the role
of endogenous renal dopamine secretion in maintaining renal function,
we investigated the effects of mcp on baseline values and dopamine
dose—response curves for renal hemodynamics and natriuresis in heal-
thy volunteers (C) and in patients with renal disease (P). Dopamine
infusion alone, in doses ranging from 1/2 to 8 pg/kg/mm, resulted in a
dose—dependent increase in ERPF and GFR with a fall in FF in C (N =
8, age 22 to 58 years) and, to a lesser degree, in P (N = 12, age 20 to 62
Baseline Mcp
C/P C/P
ERPF mi/mm
—mcp 508/225
+mcp 469/233 490/232
GFR mi/mm
—mcp 113/57
+mcp 110/57 116/59FF
—mcp 0.235/0.237
+mcp 0.235/0.241 0.230/0.241
FENa %
—mcp 1.46/1.34
+mcp 1.52/1,23 0.71/0.56
V2 2 4 8
dopamine zg/kg/mmn
C/P C/P C/P C
ERPF ml/min
—mcp 550/246 635/266 681/284 679
+mcp 517/245 509/250 670/306 615
GFR mi/mm
—mep 111/60 113/62 118/64 128
+mcp 110/62 114/60 117/66 124
FF
—mcp 0.211/0.222 0.188/0,215 0.171/0.211 0.174
-1-mcp 0.226/0.231 0.202/0.210 0.175/0.195 0.183
FENa %
—mcp 1.62/1.56 2.31/2.12 2.82/2.93 3.22
+mcp 0.84/0.63 1.25/1.07 1.60/1.68 2.83
years, baseline GFR 39-100 mI/mm) (significantly different for all doses
compared to baseline values with P < 0.05 in both groups).
Mcp, 10 mg/hr i.v., did not alter baseline values in both groups, but
shifted the dose—response curves for ERPF and FF to dopamine in C.
Dopamine infusion resulted in an increase in UNaV and FENa % for
doses 2 pg/kg/mm with a comparable response in C and P. Mcp
infusion induced a fall in UNaV and FENa % in both groups and blunted
the natriuretic response to subsequent dopamine infusion. The fall in
UNaV during mcp infusion was related to baseline GFR (r =
—0.944, P
<0.01). Mcp infusion had no effect on baseline or dopamine—induced
changes in blood pressure. We conclude that mcp acts as a dopamine—
antagonist in the human kidney. Dopamine—induced natnuresis does
not depend on changes in renal hemodynamics. Endogenous renal
dopamine secretion seems to have no role in maintaining ERPF or GFR
in healthy volunteers or in patients with renal disease, but is important
in mediating natriuresis.
Effect of ketanserin (K), a serotonin antagonist with a blocking
properties and phentolamine (P) on renal function and autoregulation of
renal blood flow (RBF). N. Lameire, E. Matthys, M. Waterloos, D.
Kesteloot, University Hospital, Gent, Belgium. It has been shown that
infusion of K results in a marked fall in blood pressure (BP). In this
study, K was compared with P and placebo (P1) on the effects on
glomerular filtration rate (GFR) and PAH clearance in the rat. Doses of
both drugs were selected to produce a similar level of BP below the
autoregulatory range. Three experimental periods were studied: before
(B), during (D) and after (A) continuous infusion in anesthetised rats.
BP mm Hg
B D A
GFR mi/mm PA
B
H1 mi/mm
D AB D A
Nrats 8 8 8
K
P
117 78b 93
125 76b 98
2.36
1.98
2.26
128b
2.42
1.5?
5.37
4.70
5.96
354k
6.10
443
P1 116 117 113 2.16 2.20 2.13 4.80 5.18 5.29
P < 0.05bp < o.oi vs B
In a second series, the effect of both K and P on autoregulation of RBF
was investigated. RBF was measured with an electromagnetic flow-
meter and renal perfusion pressure was gradually reduced from 120 to
60 mm Hg. Autoregulation of RBF was maintained for both K and P
until a level of 90 mm Hg. Autoregulation was further maintained until
a BP of 65 mm Hg with K, but not with P. RBF was still 95% of control
at BP 65 mm Hg with K, but dropped to 65% with P. Dose response
curves to increasing doses of norepinephrine (NOR) indicated that in
the doses used, K did not abolish the hypertensive reaction to NOR, in
contrast with phentolamine. In conclusion: 1) despite a similar fall in
BP, GFR and PAH clearance are maintained with K, but not with P; 2)
autoregulation of RBF is preserved, below the usual autoregulatory
range with K, and not with P; 3) these results are compatible with a role
of serotonin in regulation of RRF in the normal rat.
Anticytoplasmatic antibodies (ACPA): A marker for disease activity in
Wegener's granulomatosis. J. W. Cohen Tervaert. C.G.M. Kallenberg,
M. van der Giessen, F.J. van der Woude, G.K. van der Hem.
Department of Internal Medicine, University Hospital, Groningen, on
behaf of the Dutch Study Group of Wegener's Granulomatosis, The
Netherlands. In 1985 van der Woude et al described a specific and
sensitive test for the diagnosis of Wegener's Granulomatosis (WG). To
assess the value of this test as a marker for disease activity, we
prospectively studied the relationship between disease activity and
ACPA-titer in 31 patients with biopsy proven WG (March through
December 1986). Twenty—four patients had no signs of disease activity
at the start of the study, two patients with an established diagnosis of
WG entered the study during a relapse of their disease, and 5 patients
entered during the period of the study with newly diagnosed, active
WG. All seven patients with active disease at their entrance of the study
Abstract
had a positive ACPA-test. Of the remaining 24 patients, 6 patients
experienced 9 relapses. Every relapse was preceded by a significant rise
of the ACPA-titer. The ACPA-titer of all newly diagnosed patients and
all patients with relapses declined during treatment. In the 18 patients
who did not have a relapse, 6 demonstrated a significant rise of the
ACPA-titer. All 6 patients had minor symptoms suggestive of disease
activity concomitant with the rise in ACPA-titer. To evaluate the
significance of minor symptoms as presenting signs of the disease we
studied—retrospectively—_the time from onset of first symptoms related
to WG to the final establishment of the diagnosis. The mean time in 35
patients was 17.7 months. Forty percent of the patients had an indolent
course with only minor symptoms of 12 months duration or even longer
before the diagnosis was made. In conclusion: Quantitation of ACPA by
titration is a sensitive marker for assessing and predicting major disease
activity in WG. However, specificity is restricted by the occurrence of
rising titers in patients with minor symptoms. Otherwise, minor symp-
toms may precede major disease activity for many months.
Wegener's granulomatosis specific autoantibodies (ACPA). Characteriza-
tion of the antigen. R. Goldschmeding, P.A.T. Tetteroo, T.H. The,
A.E.G.K.R. von dem Borne. Central Laboralo,y of the Netherlands
Red Cross Blood Transfusion Service, Laboratory for Experimental
and Clinical Immunology, University of Amsterdam and Department of
Clinical Immunology, University Hospital Groningen on behalf of the
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We have characterized the antigen recognized by the anticytoplasmic
autoantibodies (ACPA) of Wegener's Granulomatosis (WG) as a human
myeloid differentiation antigen. Indirect immunofluorescence on human
and animal peripheral blood cells, cultured endothelium, and tissue
sections from various organs, showed reactivity of ACPA only with
human cells of the myeloid series. The antigen was detectable in the
promyelocytic (HL-60, U937, and the majority of CML cells), but not in
the myeloblastic (KG-la) differentiation stage. Western blot analysis of
granulocytes and monocytes revealed that, in both cell types, the
ACPA-antigen is a protein with a molecular weight of about 29 kD.
Fractionation of neutrophils revealed that the antigen is a soluble
protein of the azurophil granules without detectable expression on the
cell membrane. Degranulation upon stimulation of cytochalasin B
pretreated neutrophils leads to release of ACPA-antigen into the
medium surrounding the cells. Western blots and SDS PAGE under
reducing and non-reducing conditions of immunoprecipitated antigen,
showed that the ACPA-antigen is a single chain polypeptide with a
molecular weight of about 29 kD. The isoelectnc point of this protein
lies close to pH 7.5. These characteristics of the ACPA-antigen resem-
ble those reported for human neutrophil elastase and cathepsin G,
which have been implicated in the pathogenesis of vasculitis and
granuloma formation. We have shown however that the ACPA-antigen
is immunologically identical to neither of these enzymes.
